Business Context and Reporting Period
Kforce Inc. filed a Form 8-K on August 4, 2014, reporting the sale of its wholly-owned subsidiary, Kforce Healthcare, Inc. (KHI), which operated the company's Health Information Management segment. The transaction was effective as of 11:59 p.m. on August 3, 2014.
Key Financial Metrics
- Transaction Value: Total cash purchase price of $119.0 million, subject to a post-closing working capital adjustment.
- Accounting Treatment: The sale of KHI will be accounted for as a discontinued operation for all periods presented beginning with the third quarter of fiscal 2014.
- Pro Forma Data: Unaudited pro forma condensed consolidated financial statements are provided for the quarter ended March 31, 2014, and the years ended December 31, 2013, 2012, and 2011, reflecting the elimination of KHI's assets, liabilities, and results of operations.
- Revenue, Profit, and Cash Flow: This filing does not provide specific historical revenue, profit, or cash flow figures for Kforce Inc. or KHI; it only references the existence of pro forma statements in Exhibit 99.2.
Material Changes
The primary material change is the divestiture of the Health Information Management segment. Kforce Inc. sold all issued and outstanding stock of KHI to RCM Acquisition, Inc. This transaction removes the assets, liabilities, and operating results associated with KHI from Kforce's consolidated financial statements prospectively and retrospectively for pro forma purposes.
Outlook, Risks, and Unusual Items
- Post-Closing Services: Kforce Inc. has agreed to provide transitional services to the purchaser for a period not to exceed 12 months.
- Pro Forma Limitations: The pro forma financial statements are for illustrative purposes only and are not necessarily indicative of future operating results or financial position.
- Relationships: Other than the transaction, Kforce Inc. and its affiliates have no material relationship with the purchaser.
Investor Verification Checklist
- Review Exhibit 99.2 for the unaudited pro forma condensed consolidated financial statements to understand the impact of the divestiture on historical periods.
- Verify the final purchase price after the post-closing working capital adjustment is calculated.
- Examine the Stock Purchase Agreement (Exhibit 10.1) for specific indemnification provisions and covenants.
- Monitor future quarterly reports (10-Q) to confirm the classification of KHI results as discontinued operations.